Vivoxid Ltd, Finland, registers two new bioactive glass products in the EU
Vivoxid Ltd (Turku, Finland) has registered two new products for marketing in the European Union. Obtaining a CE mark after careful control is a significant achievement in the health care sector. CE approval was obtained for products aimed at solving medical problems in the head and neck / cranio-maxillofacial area, namely antibacterial bioactive glass granules for remedying frontal sinus and bone defects and a bioactive glass plate for the repair of the orbital floor.
Bioactive glass products hold substantial commercial potential. Bioactive glass offers a number of new application areas in the future in medicine and dentistry. The Company has a wide development programme of new bioactive glass products.
Vivoxid is located at the Turku science park and is experiencing remarkable growth. The Finnish National Fund for Research and Development (Sitra) has played a major role in developing the company as a co-owner since 2002.
BioTurku, part of the Turku Science Park, is a member of ScanBalt.
News source: Eeva Järvinen, ScanBalt web editor for Finland
5 April 2019
The German Market for Health & Care Technologies